nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant treatment for early epithelial ovarian cancer: Results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P)
|
Bolis, G. |
|
|
6 |
9 |
p. 887-893 |
artikel |
2 |
A phase I trial of intermittent high-dose α-interferon and dexamethasone in metastatic renal cell carcinoma
|
Amato, R. |
|
|
6 |
9 |
p. 911-914 |
artikel |
3 |
Awards, appointments
|
|
|
|
6 |
9 |
p. 858-859 |
artikel |
4 |
Book review
|
Bernier, J. |
|
|
6 |
9 |
p. 954 |
artikel |
5 |
Book review
|
Mirimanoff, R. |
|
|
6 |
9 |
p. 864 |
artikel |
6 |
Book review
|
Fey, Martin F. |
|
|
6 |
9 |
p. 950 |
artikel |
7 |
Brain metastases in small-cell lung cancer
|
Lassen, U. |
|
|
6 |
9 |
p. 941-944 |
artikel |
8 |
Breast cancer: To screen or not to screen?
|
|
|
|
6 |
9 |
p. 855-856 |
artikel |
9 |
Bronchoscopic treatment modalities in lung cancer, indications and limitations
|
Sutedja, G. |
|
|
6 |
9 |
p. 951-952 |
artikel |
10 |
Construction, expression and characterisation of a single chain anti-tumour antibody (scFv)-EL-2 fusion protein
|
Boleti, E. |
|
|
6 |
9 |
p. 945-947 |
artikel |
11 |
Contents of the next issue
|
|
|
|
6 |
9 |
p. 853 |
artikel |
12 |
Copyright
|
|
|
|
6 |
9 |
p. ii |
artikel |
13 |
Drugs: Holland bows to international pressure
|
Spanjer, Marjanke |
|
|
6 |
9 |
p. 854 |
artikel |
14 |
Early ovarian cancer: Treat now, later or never?
|
McGuire, William P. |
|
|
6 |
9 |
p. 865-866 |
artikel |
15 |
Effects of the hematopoietic growth factors GM-CSF, IL-3, and IL-6 on human tumor colony-forming units taken directly from patients
|
Izquierdo, M.A. |
|
|
6 |
9 |
p. 927-932 |
artikel |
16 |
FDA: Quality of life matters!
|
|
|
|
6 |
9 |
p. 858 |
artikel |
17 |
Fixed versus response-adapted MOPP/ABVD chemotherapy in Hodgkin's disease
|
Björkholm, M. |
|
|
6 |
9 |
p. 895-899 |
artikel |
18 |
Folate-based thymidylate synthase inhibitors as anticancer drugs
|
Jackman, A.L. |
|
|
6 |
9 |
p. 871-881 |
artikel |
19 |
Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advanced Hodgkin's disease
|
Diehl, V. |
|
|
6 |
9 |
p. 901-910 |
artikel |
20 |
Hypoxemia due to right-to-left shunt in the carcinoid syndrome; beneficial response to octreotide
|
Hart, D. |
|
|
6 |
9 |
p. 952-954 |
artikel |
21 |
In the U.K. National Lottery hurts charities and others
|
|
|
|
6 |
9 |
p. 855-856 |
artikel |
22 |
In this issue
|
|
|
|
6 |
9 |
p. 853 |
artikel |
23 |
Ki-l (CD30) anaplastic large-cell lymphoma in children
|
Massimino, M. |
|
|
6 |
9 |
p. 915-920 |
artikel |
24 |
Multi-day fractionated administration schedule for paclitaxel
|
Lokich, J. |
|
|
6 |
9 |
p. 883-885 |
artikel |
25 |
No more treatment for Los Angeles' impoverished cancer patients?
|
|
|
|
6 |
9 |
p. 856-857 |
artikel |
26 |
Perhaps not everyone knows that…
|
|
|
|
6 |
9 |
p. 859-860 |
artikel |
27 |
Recurrences and second primary tumours in the head and neck region: Differentiation by p53 mutation analysis
|
Gasparotto, D. |
|
|
6 |
9 |
p. 933-939 |
artikel |
28 |
Selective suppression of cytokine secretion in patients with small-cell lung cancer*
|
Fischer, J.R. |
|
|
6 |
9 |
p. 921-926 |
artikel |
29 |
Table of Contents
|
|
|
|
6 |
9 |
p. i-ii |
artikel |
30 |
The adequacy of consent forms for informing patients entering oncological clinical trials
|
Olver, I.N. |
|
|
6 |
9 |
p. 867-870 |
artikel |
31 |
Theoretical and practical aspects of paclitaxel scheduling
|
Gianni, Luca |
|
|
6 |
9 |
p. 861-863 |
artikel |
32 |
This letter was referred to the author, who responds as follows:
|
Bass, P. |
|
|
6 |
9 |
p. 952 |
artikel |
33 |
Turbulent times for cancer structures in the U.S.
|
|
|
|
6 |
9 |
p. 857-858 |
artikel |
34 |
Two phase III trials of tauromustine (TCNU) in advanced colorectal cancer
|
Smyth, J.F. |
|
|
6 |
9 |
p. 948-949 |
artikel |